Search results
Results from the WOW.Com Content Network
The Bethesda system (TBS), officially called The Bethesda System for Reporting Cervical Cytology, is a system for reporting cervical or vaginal cytologic diagnoses, [1] used for reporting Pap smear results. It was introduced in 1988 [2] and revised in 1991, [3] 2001, [1] [4] [5] and 2014. [6]
Bethesda system Category Description Risk of malignancy [19] Recommendation [19] I Non diagnostic/unsatisfactory – Repeating FNAC with ultrasound-guidance in more than 3 months II Benign (colloid and follicular cells) 0–3%: Clinical follow-up III
Colloid nodules, also known as adenomatous nodules [1] or colloid nodular goiter [2] are benign, noncancerous enlargement of thyroid tissue. [3] Although they may grow large, and there may be more than one, they are not malignant and they will not spread beyond the thyroid gland. Colloid nodules are the most common kind of thyroid nodule. [4]
Histopathology of NIFTP, H&E stain. [1]Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is an indolent thyroid tumor that was previously classified as an encapsulated follicular variant of papillary thyroid carcinoma, [2] necessitating a new classification as it was recognized that encapsulated tumors without invasion have an indolent behavior, [2] and may ...
Papillary thyroid cancer (papillary thyroid carcinoma, [1] PTC) is the most common type of thyroid cancer, [2] representing 75 percent to 85 percent of all thyroid cancer cases. [1] It occurs more frequently in women and presents in the 20–55 year age group.
Hürthle cell neoplasms can be separated into Hürthle cell adenomas (benign tumours) and carcinomas (malignant tumours) [5] arising from the follicular epithelium of the thyroid gland. [6] The latter is a relatively rare form of differentiated thyroid cancer, accounting for only 3-10% of all differentiated thyroid cancers, [ 7 ] and was ...
The Grammys executive producer Raj Kapoor told PEOPLE exclusively about the awards show highlights and how Beyoncé's late arrival just before her winning category didn't delay the run of show ...
Hürthle cell adenoma is characterized by a mass of benign Hürthle cells (Askanazy cells). [1] Typically such a mass is removed because it is not easy to predict whether it will transform into the malignant counterpart of Hürthle cell carcinoma, which is a subtype of follicular thyroid cancer. [2] [3]